Tom Gilhooly, MBChB, MRCGP - LDN in Practice (2013 Conference) (LDN, low dose naltrexone)

 

Mark Shuhkman, MD and Andrey Lev-Weissberg, MD - Psychiatric Disorders (2013 Conference) (LDN, low dose naltrexone)

 

Friday afternoon Q & A (2017 Conference) (LDN, low dose naltrexone)

Questions on use of LDN in psoriasis, Lyme Disease, cancer, thyroid, diabetes, Crohn’s, MS, Lyme, vitiligo, other autoimmune diseases, administration route, dosing, nutrition, environmental toxins, LDN receptors, thymus proteins, peptides, stem cells, Vitamin D, insurance coverage for LDN, resources for testing and other treatments.

 

 

Saturday morning Q & A (2017 Conference) (LDN, low dose naltrexone)

 

Saturday afternoon Q & A (2017 Conference) (LDN, low dose naltrexone)

 

Dr Phil Boyle - LDN in fertility (2014 Conference)

 

Dr Mark Shukhman - LDN in Psychiatry (2014 Conference) (LDN, low dose naltrexone)

 

Dr Armin Schwarzbach - Lyme Disease (2014 Conference) (LDN, low dose naltrexone)

 

Dr Tom O'Bryan - Dietary Triggers That May Inhibit the Benefits of LDN Therapy  -  Gluten Sensitivity (2014 Conference) (LDN, low dose naltrexone)